Good evening :)
Share

How to use scorecard? Learn more

Aditya Birla SL Pharma & Healthcare Fund Standard Growth

GrowthRegular
29.900.98% (+0.29)
High
Low
Returns
0.00%
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Equity

Sectoral Fund - Pharma & Health Care

Mid-size Fund

Assets Under Mgmt: ₹ 814 Cr

Very High Risk

Principle investment will be at very high risk

How to use scorecard? Learn more

Equity

Sectoral Fund - Pharma & Health Care

Mid-size Fund

Assets Under Mgmt: ₹ 814 Cr

Very High Risk

Principle investment will be at very high risk

Aditya Birla SL Pharma & Healthcare Fund Performance & Key Metrics

Aditya Birla SL Pharma & Healthcare Fund Performance & Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
2.3345.440.47
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.4953.390.58

Aditya Birla SL Pharma & Healthcare Fund Scheme InfoAditya Birla SL Pharma & Healthcare Fund Scheme Info

PlanPlanLock inLock inExit LoadExit Load
Growth0 yrs1.00%
1% on or before 30D Nil after 30D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 1,000
Initial: ₹ 1,000 Incremental: ₹ 1,000
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Aditya Birla SL Pharma & Healthcare Fund Portfolio

Aditya Birla SL Pharma & Healthcare Fund Asset Allocation

Aditya Birla SL Pharma & Healthcare Fund Asset Allocation

Actual

Target

Sep 2024

Dec 2024

Mar 2025

May 2025

ACTUAL
Cash & EquivalentsEquity2.06%97.94%

Sep 2024

Dec 2024

Mar 2025

May 2025

Tickertape Separator

Aditya Birla SL Pharma & Healthcare Fund Sector Distribution

Aditya Birla SL Pharma & Healthcare Fund Sector Distribution

Diversified ChemicalsOthersInvestment Banking & BrokerageLabs & Life Sciences ServicesPharmaceuticals0.88 %1.49 %2.17 %18.71 %76.75 %

Sep 2024

Dec 2024

Mar 2025

May 2025

Tickertape Separator

Aditya Birla SL Pharma & Healthcare Fund Sector Weightage

Aditya Birla SL Pharma & Healthcare Fund Sector Weightage

Mar 24Jun 24Sep 24Dec 24Mar 25May 2574.35%76.56%71.98%77.84%79.07%76.75%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Aditya Birla SL Pharma & Healthcare Fund Current Holdings

Aditya Birla SL Pharma & Healthcare Fund Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change

AMC Profile of Aditya Birla SL Pharma & Healthcare Fund

AMC Profile of Aditya Birla SL Pharma & Healthcare Fund

Aditya Birla Sun Life AMC Limited, is a joint venture between the Aditya Birla Group and the Sun Life Financial Inc. of Canada. The joint venture brings together Aditya Birla Group's experience in the Indian market and Sun Life's global experience.

Aditya Birla Sun Life AMC Limited, is a joint venture between the Aditya Birla Group and the Sun Life Financial Inc. of Canada. The joint venture brings together Aditya Birla Group's experience in the Indian market and Sun Life's global experience.

  • No.of Schemes

    95

  • Total AUM

    ₹ 3,89,974.88 Cr.

Aditya Birla SL Pharma & Healthcare Fund Manager Details

Aditya Birla SL Pharma & Healthcare Fund Manager Details

Aditya Birla SL Pharma & Healthcare Fund Manager Profile

Aditya Birla SL Pharma & Healthcare Fund Manager Profile

Dhaval Shah

AUM:  ₹16,182.49 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp:

Dhaval Joshi

AUM:  ₹1,53,683.56 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 15yrs

Aditya Birla SL Pharma & Healthcare Fund Manager Performance (0)

Aditya Birla SL Pharma & Healthcare Fund Manager Performance (0)

Loading...

Aditya Birla SL Pharma & Healthcare Fund Tax Implications

Aditya Birla SL Pharma & Healthcare Fund Tax Implications

Invested period < 1 year

Gains are treated as short-term capital gains and taxed at 20%

Invested period > 1 year

Gains are treated as long-term capital gains and taxed at 12.5%

Let’s calculate your returns after tax

Investment frequency

Monthly

One Time

Monthly Investment Amt. (₹)

Investment period (years)

CAGR (%)
This CAGR is calculated based on the actual past return given by the fund during the selected investment period. This is the annualised growth rate assuming monthly compounding.

+

-

You make

Frequently asked questions

Frequently asked questions

  1. What is the current price / NAV of Aditya Birla SL Pharma & Healthcare Fund?

    The current NAV of Aditya Birla SL Pharma & Healthcare Fund is ₹29.90, as of 20th June 2025.

  2. What are the returns of Aditya Birla SL Pharma & Healthcare Fund?

    The Aditya Birla SL Pharma & Healthcare Fund was launched on 10th July 2019. This mutual fund's past returns are as follows:
    • 1 Year Returns: 9.97%
    • 3 Year Returns: 23.33%
    • 5 Year Returns: 18.85%

  3. What are the top 5 sectoral holdings of Aditya Birla SL Pharma & Healthcare Fund?

    The top sectors Aditya Birla SL Pharma & Healthcare Fund has invested in are as follows:
    • Pharmaceuticals | 76.75%
    • Labs & Life Sciences Services | 18.71%
    • Investment Banking & Brokerage | 2.17%
    • Others | 1.49%
    • Diversified Chemicals | 0.88%
    This data is as on 20th June 2025.

  4. What are the top 5 holdings of Aditya Birla SL Pharma & Healthcare Fund?

    The top 5 holdings for Aditya Birla SL Pharma & Healthcare Fund are as follows:
    • Sun Pharmaceutical Industries Ltd | 12.08%
    • Cipla Ltd | 7.69%
    • Apollo Hospitals Enterprise Ltd | 7.18%
    • Abbott India Ltd | 6.09%
    • Torrent Pharmaceuticals Ltd | 5.47%
    This data is as on 20th June 2025.

  5. What is the asset allocation of Aditya Birla SL Pharma & Healthcare Fund?

    The asset allocation for Aditya Birla SL Pharma & Healthcare Fund is as follows:
    • Equity | 97.94%
    • Cash & Equivalents | 2.06%
    This data is as on 20th June 2025.

  6. What is the AUM of Aditya Birla SL Pharma & Healthcare Fund?

    The AUM (i.e. assets under management) of Aditya Birla SL Pharma & Healthcare Fund is ₹814.18 Cr as of 20th June 2025.

  7. What is the expense ratio of Aditya Birla SL Pharma & Healthcare Fund?

    The expense ratio of Aditya Birla SL Pharma & Healthcare Fund Plan is 2.33 as of 20th June 2025.

  8. What is the alpha ratio of Aditya Birla SL Pharma & Healthcare Fund?

    The alpha ratio for the Aditya Birla SL Pharma & Healthcare Fund is -2.06

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. What is the volatility or standard deviation of Aditya Birla SL Pharma & Healthcare Fund?

    The volatility or standard deviation for the Aditya Birla SL Pharma & Healthcare Fund is 14.47

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. What is the sharpe ratio of Aditya Birla SL Pharma & Healthcare Fund?

    The Sharpe ratio for the Aditya Birla SL Pharma & Healthcare Fund is 0.47

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. What is the Sortino ratio of Aditya Birla SL Pharma & Healthcare Fund?

    The Sortino Ratio for the Aditya Birla SL Pharma & Healthcare Fund is 0.05

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. What is the Price to Earnings (PE) ratio of Aditya Birla SL Pharma & Healthcare Fund?

    The PE ratio of Aditya Birla SL Pharma & Healthcare Fund is 45.44, while category PE ratio is 53.39.